Abstract. Mastomys [Praomys(mastomys) coucha] of both sexes have morphologically functional prostates. To evaluate endocrine control of the prostate and other genital organs in mastomys, TAP-144-SR, a biodegradable sustained-release formulation of a potent Gonadotrophin-releaseing hormone (GnRH) agonist (leuprolide acetate), which is able to induce desensitization of the pituitary-gonadal axis, was used in this study. Three weeks after a single sc injection of TAP-144-SR (5 mg/kg), the mastomys were autopsied.
(J. Reprod. Dev. 40: 329-335, 1994) H ypophysectomized animals have been widely used to study endocrine control of reproduction. However, hypophysectomy eliminates not only luteinizing hormone (LH) and follicle stimulating hormone (FSH) but also all other pituitary hormones including hormones essential to maintain homeostasis. Therefore, hypophysectomized animals are usually subject to severe physiological damage which may nonspecifically affect reproductive function. Thus, it is occasionally difficult to obtain precise information on specific actions of LH and FSH by hypophysectomy and hormonal replacement administration. 
Treatment of animals with TAP-144-SR
The sustained-release formulation of leuprolide [D-Leu6-(Des-Gly10-NH2)-GnRH ethylamide] acetate (TAP-144-SR) was supplied by Takeda Chemical industries Ltd. Adult (3-5 months of age) mastomys were administered a single subcutaneous injection of TAP-144-SR (5 mg/kg). Mastomys in the control group were given only the suspension vehicle (an aqueous solution containing 5% mannitol, 4% polysorbate 80, and 0.5% sodium carboxymethyl cellulose). Three weeks after injection, blood samples were collected by heart puncture under light ether anesthesia, and then the animals were killed by cervical dislocation. Pituitary glands and genital organs were removed and weighed. 
Results

Organ weights
The body and organ weights of control and TAP-144-SR treated males are summarized in Table 1 . Body weight and the anterior pituitary weight of TAP-144-SR treated males were comparable to those of the control males. The weights of testes, prostates and seminal vesicles in the TAP-144-SR treated males were significantly lower than those in controls (P<0.05, P<0.05 and P<0.001, respectively). As shown Table 2 , body weight and weight of the anterior pituitary of TAP-144-SR treated females were also comparable to those of control females.
The weights of ovaries and uteri of TAP-144-SR treated females were significantly lower than those of controls (P<0.05 and P<0.05, respectively, Table 2 ). Although mean weight of prostates in the TAP-144-SR treated females was slightly lower than that in controls, the difference or growing antral follicles (Fig. 1B) . This observation shows that ovulation did not occur in these animals for a long time after TAP-144-SR administration. The uteri of control animals had a thick stromal layer of endometrium and high columnar epithelial cells (Fig. 1C and E) . In the uteri of TAP-144-SR animals, the cavity and stromal layer of endometrium were shrunken, and epithelial cells became cuboidal (Fig. 1D and F) .
Testes of TAP-144-SR treated males (Fig. 2C ) and controls ( Fig. 2A) underwent spermatogenesis. However, the leydig cells of the TAP-144-SR animals (Fig. 2D) were smaller than those of the controls (Fig. 2B) .
The prostates of male controls had many large cavities that were enclosed by the epithelium, which had cuboidal cells, and the cavities were filled with a secretion stained by eosin (Fig. 3A) . In the prostate glands of the control females, the epithelium, which consisted of tall, columnar cells, formed complex folds (Fig. 3B) . In the prostates of TAP-144-SR treated males (Fig. 3C) , the cavities were relatively small in comparison with those of controls, and the structure of epithelium was somewhat similar to that of control females. No remarkable histological changes were observed in the TAP-144-SR treated female prostates (Fig. 3D) .
Steroids
Serum levels of sex steroids are summarized in Table 3 
